A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

June 30, 2010

Conditions
Hepatitis C
Interventions
DRUG

ABT-072

See arm description for more information

DRUG

Placebo

See arm description for more information

Trial Locations (1)

Unknown

Kagoshima

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Abbott Japan Co.,Ltd

INDUSTRY

lead

Abbott

INDUSTRY